Stephen Locarnini Selected Research

N-acetyltalosaminuronic acid (NAT)

11/2007

Genotyping and genomic sequencing in clinical practice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen Locarnini Research Topics

Disease

42	Chronic Hepatitis B 01/2022 - 09/2002
37	Hepatitis B 01/2022 - 02/2002
30	Infections 01/2022 - 02/2002
9	Coinfection 01/2020 - 09/2008
7	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 01/2009
7	Liver Diseases (Liver Disease) 01/2018 - 12/2002
6	Persistent Infection 01/2018 - 06/2004
6	Hepatitis 11/2015 - 02/2002
6	Fibrosis (Cirrhosis) 04/2015 - 09/2008
5	Disease Progression 01/2017 - 02/2002
3	HIV Infections (HIV Infection) 05/2013 - 05/2004
3	Liver Failure 10/2004 - 02/2002
2	Viremia 01/2016 - 05/2013
2	Hepatitis C 01/2015 - 04/2002
2	Virus Diseases (Viral Diseases) 06/2012 - 01/2008
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2010 - 09/2008
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2021
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Superinfection 01/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2011
1	Inflammation (Inflammations) 09/2010
1	Necrosis 01/2009
1	Hepatoblastoma 01/2009
1	Immune Reconstitution Inflammatory Syndrome 01/2007
1	Iron Overload 04/2002
1	Chronic Hepatitis C 04/2002
1	beta-Thalassemia (Cooley's Anemia) 04/2002
1	Massive Hepatic Necrosis 01/2002

Drug/Important Bio-Agent (IBA)

26	Antiviral Agents (Antivirals)IBA 01/2020 - 02/2002
20	Hepatitis B e AntigensIBA 01/2022 - 06/2005
17	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 09/2002
15	DNA (Deoxyribonucleic Acid)IBA 04/2021 - 01/2004
11	Pharmaceutical PreparationsIBA 12/2015 - 02/2002
11	Lamivudine (Epivir)FDA Link 03/2012 - 01/2002
8	VaccinesIBA 01/2018 - 12/2004
7	Proteins (Proteins, Gene)FDA Link 11/2013 - 05/2003
6	Tenofovir (Viread)FDA Link 11/2017 - 01/2005
5	Biomarkers (Surrogate Marker)IBA 11/2019 - 11/2011
4	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2008
4	NucleotidesIBA 01/2020 - 07/2003
4	Surface Antigens (Surface Antigen)IBA 06/2012 - 08/2003
4	NucleosidesIBA 01/2010 - 02/2002
4	adefovir dipivoxil (Hepsera)FDA Link 05/2008 - 07/2003
3	AntigensIBA 01/2022 - 11/2007
3	Nucleic AcidsIBA 01/2022 - 11/2007
3	Alanine Transaminase (SGPT)IBA 04/2015 - 10/2004
2	entecavir FDA Link 01/2022 - 12/2004
2	EpitopesIBA 01/2022 - 11/2019
2	lipoarabinomannan (LAM)IBA 01/2017 - 08/2009
2	TolerogenIBA 03/2011 - 01/2010
2	RacivirIBA 08/2009 - 05/2008
2	Hepatitis B virus P proteinIBA 05/2009 - 09/2008
2	CytokinesIBA 01/2009 - 05/2004
2	Toll-Like Receptor 2IBA 01/2009 - 08/2006
2	InterferonsIBA 07/2007 - 04/2002
1	ARC-520IBA 01/2022
1	Viral RNAIBA 01/2020
1	AntibodiesIBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 06/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017
1	Terminator Codon (Termination Codon)IBA 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 01/2015
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2015
1	Viral ProteinsIBA 09/2012
1	Interleukin-8 (Interleukin 8)IBA 01/2009
1	NF-kappa B (NF-kB)IBA 01/2009
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2009
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2009
1	pgRNAIBA 09/2008
1	Emtricitabine (Emtriva)FDA Link 05/2008
1	N-acetyltalosaminuronic acid (NAT)IBA 11/2007
1	nasIBA 07/2007
1	Neutralizing AntibodiesIBA 01/2007
1	Adenosine (Adenocard)FDA LinkGeneric 01/2005
1	Circular DNAIBA 06/2004
1	Immunoglobulins (Immunoglobulin)IBA 08/2003
1	Famciclovir (Famvir)FDA LinkGeneric 05/2003
1	Interferon-alpha (Interferon Alfa)IBA 04/2002
1	IronIBA 04/2002
1	BilirubinIBA 02/2002
1	hepatitis B hyperimmune globulinIBA 02/2002
1	Transaminases (Aminotransferases)IBA 02/2002

Therapy/Procedure

36	Therapeutics 01/2020 - 02/2002
6	Highly Active Antiretroviral Therapy (HAART) 01/2016 - 05/2004
5	Drug Therapy (Chemotherapy) 06/2012 - 12/2002
3	Liver Transplantation 06/2012 - 02/2002
2	Cell Transplantation 02/2005 - 09/2002
2	Transplantation 02/2005 - 09/2002
2	Combination Drug Therapy (Combination Chemotherapy) 01/2004 - 09/2002
1	Salvage Therapy 01/2017
1	Immunomodulation 10/2011
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2005